Treatment potential and cost projection regarding use of icatibant or lanadelumab for therapy of COVID-19 associated respiratory distress syndrome
British Journal of Clinical Pharmacology
; 87(3):1613-1613, 2021.
Article
in English
| Web of Science | ID: covidwho-1158688
Search on Google
Collection:
Databases of international organizations
Database:
Web of Science
Language:
English
Journal:
British Journal of Clinical Pharmacology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS